trình nghiên cứu ung th−, tr. 87.
43. Trần Hữu T−ớc, (1967). 612 ca UTVMH gặp tại khoa Tai - Mũi -
Họng bệnh viện Bạch Mai trong 10 năm (1955 - 1964). Hội Tai - Mũi - Họng số 1, tr. 16.
44. Nguyễn Bá Đức, (1995). Ung th− học lâm sàng tập 1. Nhà xuất bản Y
học, Hà nội, tr.79.
Tài liệu tiếng Anh
45. Abbas A.K., (1985). Basic of immunology,2nd Editon, pp. 77.
46. Abbas A.K., (2000). “Immunity in tumors”, Cellular and molecular
immunology 4th Edition, pp. 384-403.
47. Abderrahim F et al. (1995). “Biology and treatment of nasopharyngeal
cancer”, Current Opinion in Oncology, 7, pp. 255-263.
48. Anderson Anvret M, Fosby N, Klein G, Henle W, (1977). Studies on
the occurence of Epstein Barr virus DNA in nasopharyngeal carcinoma in comparison with tumor of other head and neck region. Int. J. cancer 20, pp. 702-707.
49. Anderson Anvret M, Klein G, Henle W. Biorlund A., (1979).
Relationship between the EBV genom and nasopharyngeal carcinoma in Caucasian patients. Int. J. cancer. 23, pp. 762-767.
50. Akao I, Sato Y, et al, (1991). “Detection of EBV- DNA in formalin
fixed paraffin embedded tissue of NPC using PCR in situ hibridization”, Laryngoscope, 101(3), pp. 279-283.
51. Ammatuna P, DeThe G, et al, (1988). “Serological and immunohistological assessment of Epstein-Barr virus infection in immunohistological assessment of Epstein-Barr virus infection in sicilian patients with suspected nasopharyngeal carcinoma”, Microbiologica, 11, pp. 89-94.
52. Baker S.R, and Wolfe R.A., (1982), “Prognostic factors of
nasopharyngeal malignancy”, Cancer, 49, pp. 163-169.
53. Beverly P, (2000). Tumor immunology. Tumor antigen. Mosby, pp.
17.2
54. Bortolin M.T, Pratesi C, Dolcetti R, Bidoli E, Vaccher E, Zanussi S,
Tedeschi R, De Paoli P, (2006). Clinical value of Epstein-Barr virus
DNA levels in peripheral blood samples of Italian patients with undifferentiated carcinoma of nasopharyngeal type. Microbiology, Immunology and Virology Unit, Centro di Riferimento Oncologico, IRCCS, Via Pedemontana Occidentale, 12, Aviano (PN) 33081, Italy; 233(2):247-54.
55. Bouzid M, Djennaoui D, et al, (1994). “Epstein-Barr virus genotypes
in NPC biopsies from North Africa”, Int. J. Cancer, 56, pp. 468- 473.
56. Burt R.D, (1994). A protective association between the HLA - A2
antigen and NPC in US Caucassians. Fred Hutchinson Cancer research. Seattle:211
57. Chen X, Cai Y, Sun N, (1994). The expression of MHC, EBV nuclear
antigen and the infiltration of T lymphocyte subset in nasopharyngeal biopsy tissues. Zhonghua Er Bi Yan Hou Ke Za Zhi. Guangdong medical colege, Zhangiang. 29 (1), pp. 6-9.
58. Charles A, Janeway, Paul travers, Simon Hunt et al. (1997), “Using
the immune response to attack tumors”, Immunobiology, third edition, pp. 13.